{"entity":{"type":"insider","cik":"0001766329","url":"/insider/0001766329","json_url":"/insider/0001766329.json","name":"Gross Paul Edward","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":27,"first":"2019-03-06","last":"2022-11-03","span_basis":"filed_date"},"name_variants":[{"name":"Gross Paul Edward","source":"filing","n_filings":27,"first_seen":"2019-03-06","last_seen":"2022-11-03"}],"transactions":[{"id":6620782,"accession":"0000899243-22-034898","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-034898","line_url":"/filing/0000899243-22-034898","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4730.0,"shares_display":"4,730","price_per_share":0.9829,"price_display":"0.98","price_state":"stated","total_value":4649.117,"total_display":"4,649.12","total_whole":"4,649","shares_owned_after":95840.0,"shares_owned_after_display":"95,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider","n_lines":2},{"id":6443907,"accession":"0000899243-22-030420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030420","line_url":"/filing/0000899243-22-030420#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2308.0,"shares_display":"2,308","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":2769.6,"total_display":"2,769.60","total_whole":"2,770","shares_owned_after":92812.0,"shares_owned_after_display":"92,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6089641,"accession":"0000899243-22-027575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-027575","line_url":"/filing/0000899243-22-027575","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4807.0,"shares_display":"4,807","price_per_share":1.4611,"price_display":"1.46","price_state":"stated","total_value":7023.5077,"total_display":"7,023.51","total_whole":"7,024","shares_owned_after":87601.0,"shares_owned_after_display":"87,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-03","scope":"insider","n_lines":2},{"id":6670252,"accession":"0000899243-22-020945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020945","line_url":"/filing/0000899243-22-020945#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2403.0,"shares_display":"2,403","price_per_share":0.6424,"price_display":"0.64","price_state":"stated","total_value":1543.6872,"total_display":"1,543.69","total_whole":"1,544","shares_owned_after":84615.0,"shares_owned_after_display":"84,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6318305,"accession":"0000899243-22-016293","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016293","line_url":"/filing/0000899243-22-016293","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4570.0,"shares_display":"4,570","price_per_share":1.9698,"price_display":"1.97","price_state":"stated","total_value":9001.986,"total_display":"9,001.99","total_whole":"9,002","shares_owned_after":79393.0,"shares_owned_after_display":"79,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider","n_lines":2},{"id":6139225,"accession":"0000899243-22-009058","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-009058","line_url":"/filing/0000899243-22-009058","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10706.0,"shares_display":"10,706","price_per_share":1.866,"price_display":"1.87","price_state":"stated","total_value":19977.396,"total_display":"19,977.40","total_whole":"19,977","shares_owned_after":76278.0,"shares_owned_after_display":"76,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":6087686,"accession":"0000899243-22-004569","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-004569","line_url":"/filing/0000899243-22-004569","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5436.0,"shares_display":"5,436","price_per_share":1.9396,"price_display":"1.94","price_state":"stated","total_value":10543.6656,"total_display":"10,543.67","total_whole":"10,544","shares_owned_after":63999.0,"shares_owned_after_display":"63,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider","n_lines":2},{"id":5365083,"accession":"0000899243-21-046762","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046762","line_url":"/filing/0000899243-21-046762#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":248.0,"shares_display":"248","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":744.0,"total_display":"744.00","total_whole":"744","shares_owned_after":61357.0,"shares_owned_after_display":"61,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-03","scope":"insider"},{"id":5455766,"accession":"0000899243-21-042701","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-042701","line_url":"/filing/0000899243-21-042701","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4523.0,"shares_display":"4,523","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":20579.65,"total_display":"20,579.65","total_whole":"20,580","shares_owned_after":58459.0,"shares_owned_after_display":"58,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider","n_lines":2},{"id":5038220,"accession":"0000899243-21-035115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-035115","line_url":"/filing/0000899243-21-035115#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":1217.61,"total_display":"1,217.61","total_whole":"1,218","shares_owned_after":55318.0,"shares_owned_after_display":"55,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":5487859,"accession":"0000899243-21-031438","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-031438","line_url":"/filing/0000899243-21-031438","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4507.0,"shares_display":"4,507","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":21723.74,"total_display":"21,723.74","total_whole":"21,724","shares_owned_after":52413.0,"shares_owned_after_display":"52,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider","n_lines":2},{"id":4974548,"accession":"0000899243-21-021859","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-021859","line_url":"/filing/0000899243-21-021859#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231.0,"shares_display":"231","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":1300.53,"total_display":"1,300.53","total_whole":"1,301","shares_owned_after":49262.0,"shares_owned_after_display":"49,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-03","scope":"insider"},{"id":4204374,"accession":"0000899243-21-018274","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-018274","line_url":"/filing/0000899243-21-018274","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4838.0,"shares_display":"4,838","price_per_share":5.54,"price_display":"5.54","price_state":"stated","total_value":26802.52,"total_display":"26,802.52","total_whole":"26,803","shares_owned_after":47312.0,"shares_owned_after_display":"47,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider","n_lines":3},{"id":4759710,"accession":"0000899243-21-009500","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-009500","line_url":"/filing/0000899243-21-009500","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":456.0,"shares_display":"456","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":2868.24,"total_display":"2,868.24","total_whole":"2,868","shares_owned_after":43521.0,"shares_owned_after_display":"43,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":5454826,"accession":"0000899243-21-004677","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-004677","line_url":"/filing/0000899243-21-004677","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11873.0,"shares_display":"11,873","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":94627.81,"total_display":"94,627.81","total_whole":"94,628","shares_owned_after":42945.0,"shares_owned_after_display":"42,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider","n_lines":3},{"id":2385521,"accession":"0000899243-20-032939","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-032939","line_url":"/filing/0000899243-20-032939","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":457.0,"shares_display":"457","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":2234.73,"total_display":"2,234.73","total_whole":"2,235","shares_owned_after":30693.0,"shares_owned_after_display":"30,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider","n_lines":2},{"id":3319896,"accession":"0000899243-20-030471","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030471","line_url":"/filing/0000899243-20-030471#line-4","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1152.0,"shares_display":"1,152","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":5679.36,"total_display":"5,679.36","total_whole":"5,679","shares_owned_after":28434.0,"shares_owned_after_display":"28,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider"},{"id":3075462,"accession":"0000899243-20-024510","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-024510","line_url":"/filing/0000899243-20-024510","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":2305.5,"total_display":"2,305.50","total_whole":"2,306","shares_owned_after":27030.0,"shares_owned_after_display":"27,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-08","scope":"insider","n_lines":2},{"id":3319885,"accession":"0000899243-20-030471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030471","line_url":"/filing/0000899243-20-030471#line-1","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1382.0,"shares_display":"1,382","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":6813.26,"total_display":"6,813.26","total_whole":"6,813","shares_owned_after":30119.0,"shares_owned_after_display":"30,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-11-05","scope":"insider"},{"id":2456637,"accession":"0000899243-20-021481","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-021481","line_url":"/filing/0000899243-20-021481","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2506.0,"shares_display":"2,506","price_per_share":5.92,"price_display":"5.92","price_state":"stated","total_value":14835.52,"total_display":"14,835.52","total_whole":"14,836","shares_owned_after":26433.0,"shares_owned_after_display":"26,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider","n_lines":2},{"id":2857505,"accession":"0000899243-20-015501","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015501","line_url":"/filing/0000899243-20-015501","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":470.0,"shares_display":"470","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":3304.1,"total_display":"3,304.10","total_whole":"3,304","shares_owned_after":23315.0,"shares_owned_after_display":"23,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider","n_lines":2},{"id":2375715,"accession":"0000899243-20-012243","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-012243","line_url":"/filing/0000899243-20-012243","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2213.0,"shares_display":"2,213","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":17925.3,"total_display":"17,925.30","total_whole":"17,925","shares_owned_after":22755.0,"shares_owned_after_display":"22,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider","n_lines":2},{"id":2952392,"accession":"0000899243-20-007183","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-007183","line_url":"/filing/0000899243-20-007183","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":475.0,"shares_display":"475","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":3420.0,"total_display":"3,420.00","total_whole":"3,420","shares_owned_after":19345.0,"shares_owned_after_display":"19,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider","n_lines":2},{"id":3194706,"accession":"0000899243-20-003480","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-003480","line_url":"/filing/0000899243-20-003480","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10470.0,"shares_display":"10,470","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":88052.7,"total_display":"88,052.70","total_whole":"88,053","shares_owned_after":18788.0,"shares_owned_after_display":"18,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider","n_lines":2},{"id":8234480,"accession":"0000899243-19-028563","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028563","line_url":"/filing/0000899243-19-028563","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":466.0,"shares_display":"466","price_per_share":14.59,"price_display":"14.59","price_state":"stated","total_value":6798.94,"total_display":"6,798.94","total_whole":"6,799","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider","n_lines":2},{"id":8197740,"accession":"0000899243-19-023017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-023017","line_url":"/filing/0000899243-19-023017","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":495.0,"shares_display":"495","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":2578.95,"total_display":"2,578.95","total_whole":"2,579","shares_owned_after":5935.0,"shares_owned_after_display":"5,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-06","scope":"insider","n_lines":2},{"id":8340596,"accession":"0000899243-19-015788","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-015788","line_url":"/filing/0000899243-19-015788","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":453.0,"shares_display":"453","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":6826.71,"total_display":"6,826.71","total_whole":"6,827","shares_owned_after":4316.0,"shares_owned_after_display":"4,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider","n_lines":2},{"id":7934460,"accession":"0000899243-19-006457","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-006457","line_url":"/filing/0000899243-19-006457#line-4","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001766329","owner_name":"Gross Paul Edward","owner_display_name":"Gross Paul Edward","owner_url":"/insider/0001766329","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1088.0,"shares_display":"1,088","price_per_share":29.29,"price_display":"29.29","price_state":"stated","total_value":31867.52,"total_display":"31,867.52","total_whole":"31,868","shares_owned_after":3739.0,"shares_owned_after_display":"3,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-05","filed_date":"2019-03-06","scope":"insider"}],"collapsed":true,"next_cursor":"2019-03-05|7934460","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":27,"first_seen":"2019-03-06","last_seen":"2022-11-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001766329","retrieved_at":"2026-08-27T20:59:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}